Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1456]

Ovarian cancer subtypes may predict response to bevacizumab

Ovarian cancer subtypes may predict response to bevacizumab

ASCO 2014: HPV-targeted adoptive T cell therapy may provide a new strategy for advanced cervical cancer

ASCO 2014: HPV-targeted adoptive T cell therapy may provide a new strategy for advanced cervical cancer

ASCO 2014: Adjuvant exemestane is more effective than tamoxifen when combined with ovarian function suppression in young women with hormone-sensitive, early-stage breast cancer

ASCO 2014: Adjuvant exemestane is more effective than tamoxifen when combined with ovarian function suppression in...

ASCO 2014: New combo, cediranib plus olaparib, significantly increases progression-free survival in recurrent ovarian cancer

ASCO 2014: New combo, cediranib plus olaparib, significantly increases progression-free survival in recurrent...

ASCO 2014: Lower-dose radiation safe for certain lower-risk, HPV-positive head and neck cancers

ASCO 2014: Lower-dose radiation safe for certain lower-risk, HPV-positive head and neck cancers

Current guidelines underestimate US cervical cancer incidence and older women’s risk of developing the disease

Current guidelines underestimate US cervical cancer incidence and older women’s risk of developing the disease

Asprin could combat permanent hearing loss caused by cancer drug

Asprin could combat permanent hearing loss caused by cancer drug

Researchers identify potential new strategy to treat ovarian cancer

Researchers identify potential new strategy to treat ovarian cancer

AACR urges FDA regulation of all tobacco products, including e-cigarettes

AACR urges FDA regulation of all tobacco products, including e-cigarettes

AACR: Irregular menstruation may predict Increased risk of death from ovarian cancer

AACR: Irregular menstruation may predict Increased risk of death from ovarian cancer

More from ecancer